Matches in Wikidata for { <http://www.wikidata.org/entity/Q61938196> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q61938196 description "assaig clínic" @default.
- Q61938196 description "clinical trial" @default.
- Q61938196 description "clinical trial" @default.
- Q61938196 description "clinical trial" @default.
- Q61938196 description "clinical trial" @default.
- Q61938196 description "ensaio clínico" @default.
- Q61938196 description "ensayo clínico" @default.
- Q61938196 description "ensayu clínicu" @default.
- Q61938196 description "essai clinique" @default.
- Q61938196 description "klinisch onderzoek" @default.
- Q61938196 description "клінічне випробування" @default.
- Q61938196 description "կլինիկական փորձարկում" @default.
- Q61938196 description "临床试验" @default.
- Q61938196 name "Prospective, Post Marketing Surveillance Study On Erbitux® (Cetuximab) in Patients With Locally Advanced or Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck in Korea" @default.
- Q61938196 type Item @default.
- Q61938196 label "Prospective, Post Marketing Surveillance Study On Erbitux® (Cetuximab) in Patients With Locally Advanced or Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck in Korea" @default.
- Q61938196 prefLabel "Prospective, Post Marketing Surveillance Study On Erbitux® (Cetuximab) in Patients With Locally Advanced or Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck in Korea" @default.
- Q61938196 P1132 Q61938196-27E82186-3FFD-40E0-AD49-2A0011D7092D @default.
- Q61938196 P1476 Q61938196-0B1F2CE5-7EFC-4BA0-8045-037868FD374E @default.
- Q61938196 P3098 Q61938196-1B4F1B64-9D62-48CC-9057-F7E53005BB85 @default.
- Q61938196 P31 Q61938196-79FE5DA8-FA78-49A9-8A8B-BC4E75E26367 @default.
- Q61938196 P4844 Q61938196-F69D8E62-D4F4-4F48-B16F-CC11104B6A90 @default.
- Q61938196 P580 Q61938196-D8CF2726-90B4-4964-9CD6-F745768DF583 @default.
- Q61938196 P582 Q61938196-455F6085-5AC5-451A-A6BA-223B02CD2D09 @default.
- Q61938196 P6153 Q61938196-2031A454-38C0-4C81-8481-F5FD4CCB267D @default.
- Q61938196 P8005 Q61938196-0613A188-3D66-4CFB-B222-1B961DC5874E @default.
- Q61938196 P8363 Q61938196-ABBA0994-4CCB-42B8-9FC6-390DAF36779F @default.
- Q61938196 P1132 "+221" @default.
- Q61938196 P1476 "A Korean Post Marketing Surveillance Study On Erbitux® (Cetuximab) In Patients With Locally Advanced or Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck (SCCHN)" @default.
- Q61938196 P3098 "NCT01075828" @default.
- Q61938196 P31 Q30612 @default.
- Q61938196 P4844 Q420296 @default.
- Q61938196 P580 "2009-03-01T00:00:00Z" @default.
- Q61938196 P582 "2014-07-01T00:00:00Z" @default.
- Q61938196 P6153 Q489488 @default.
- Q61938196 P8005 Q76651189 @default.
- Q61938196 P8363 Q818574 @default.